Tag: Tryptamine Therapeutics

The Daily Hit: October 30, 2024

News from: Drug Enforcement Administration, Massachusetts, Florida, Tryptamine Therapeutics and more. The Daily Hit is a recap of the top financial news stories for Wednesday, October 30, 2024. On the Site DEA begins picking witnesses for December cannabis hearing NCIA confirms it is among those approved to speak at the hearing. Read more here. Massachusetts […]

Tryptamine Therapeutics raises A$6M to advance psychedelic pipeline

Australian biotech firm Tryptamine Therapeutics Limited (ASX: TYP) secured A$6 million in new funding through a strategic placement. The placement, priced at A$0.02 per share, was backed by cornerstone investors that included Merchant Biotech Fund and biotech investor Daniel Tillett, who will join the company’s board as a non-executive director, the company said in an […]